In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin

In vitro anticancer activity and oxidative molecular damage by cannabidiol administered alone and in combination with epirubicin

Evidence suggests that the non-psychotropic phytocannabinoid cannabidiol (CBD) has anticancer activity on different cell lines and in animal models. The DNA-damaging drug epirubicin (EPI) is widely used for the treatment of malignant tumours. In this study we examined the effectiveness of CBD admini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Margarita Zhelyazkova, Nadya Hristova-Avakumova, Lozan Todorov, Georgi Momekov
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
antagonism
cannabidiol
combination chemotherapy
epirubicin
free radicals
oxidative molecular damage
Biotechnology
TP248.13-248.65
Acceso en línea:https://doaj.org/article/561a735bda53473f927a09373311a1bb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/561a735bda53473f927a09373311a1bb

Ejemplares similares